Amir Moradi
Otolaryngology · Vista, CANPI 1467567032
Payments from drug & device makers
Across 701 payments — averaging $3683.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2M
- Merz North America, Inc.$569K
- Galderma Laboratories, L.p.$26K
- Revance Therapeutics, Inc.$101
- Endo Pharmaceuticals Inc.$46
Across 53 payments — averaging $1661.99 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merz North America, Inc.$69K
- AbbVie$19K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 582 | $1,986,521 |
| Merz North America, Inc. | 97 | $569,485 |
| Galderma Laboratories, L.p. | 17 | $25,843 |
| Revance Therapeutics, Inc. | 4 | $101 |
| Endo Pharmaceuticals Inc. | 1 | $46 |
How this compares
$2,581,994 in reported general payments places this provider in the 95th percentile of 1,021 otolaryngology providers in California.
Other otolaryngology in Vista
- Randall OwRoseville$4.3M
- Brian WeeksSan Diego$1.6M
- Charles LimbSan Francisco$1.5M
- Andrew BerosSan Diego$688K
- Paul SchalchChula Vista$573K
- Steven DavisTorrance$544K
- Arnaud BewleySacramento$541K
- Keith BlackwellLos Angeles$349K
- Kalpna DurairajSun Valley$348K
- Martin HoppLos Angeles$321K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.